Trial reportPloS one2026
The impact of insole wedge height on knee alignment, joint space width, and patient-reported outcomes in medial knee OA.
Trial report in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionLateral wedge insoles (LWIs) are a recommended conservative treatment for medial knee osteoarthritis (OA), yet the optimal wedge height remains unclear. This randomized controlled trial evaluated the effects of different LWI heights on radiographic outcomes in patients with medial knee OA.
methodsThis study employed a randomized, controlled, parallel-arm design with a sequential, within-subject dose-escalation intervention arm. Thirty-four participants with mild-to-moderate medial knee OA (Kellgren- Lawrence grade <3) were randomized into a case group (n = 17) receiving custom LWIs (4 mm, 8 mm,12 mm, 16 mm) and a control group (n = 17) receiving standard care. Radiographic assessments (femorotibial angle [FTA], medial joint space width [MJSW]) and patient-reported outcomes (WOMAC) were performed at baseline and follow-up. Mixed ANOVA analyzed group and time effects.
resultsThe 12 mm LWI significantly reduced varus alignment (FTA: 177.3° ± 2.8 vs. 178.1° ± 2.7 with 4 mm, p < 0.05) in the non-dominant limb. No significant FTA change was observed in the dominant limb, suggesting that limb-specific loading history may modulate biomechanical responsiveness to orthotic correction. No significant FTA changes occurred in the dominant limb. MJSW remained stable in the case group but narrowed in controls (3.04 ± 0.7 mm vs. 3.16 ± 0.8 mm, p < 0.05). The 16 mm LWI was discontinued due to poor tolerability (11/17 participants). The LWI group also showed significant improvements in WOMAC total and pain scores compared to controls.
conclusionAmong the clinically tolerable LWI heights tested, the 12 mm wedge provided the best balance between biomechanical efficacy and patient tolerability. It significantly improved varus alignment (in the non-dominant limb), halted joint space narrowing, and reduced pain and overall symptoms. The 16 mm wedge was poorly tolerated (11/17 participants) and was therefore deemed clinically impractical. Future studies should explore personalized height selection and long-term outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.